Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boehringer Avoids Pradaxa Trial, Board Chair Deposition With $650 Mil. Settlement

May 29 2014

• By Brenda Sandburg

Related Content

Pradaxa Bleeding Risk Gets Deeper FDA Scrutiny In Mini-Sentinel Project

Jan 07 2014

Pradaxa Bleeding Deaths Spur FDA Concerns, European Label Changes

Dec 07 2011

Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue

Nov 02 2012

Related Companies

Boehringer Ingelheim GmbH

Additional Topics

United States Safety Legal Issues BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window